Rome 2009. Disclosure. The speaker cooperates with the following companies. BMeye Drager-Siemens Pulsion. perelao@shani.net



Similar documents
The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy

Fundamentals of Critical Care: Hemodynamics, Monitoring, Shock

Edwards FloTrac Sensor & Edwards Vigileo Monitor. Understanding Stroke Volume Variation and Its Clinical Application

BUNDLES IN 2013: SURVIVING SEPSIS CAMPAIGN

Vasopressors. Judith Hellman, M.D. Associate Professor Anesthesia and Perioperative Care University of California, San Francisco

Keep an Eye on Costs

VASOPRESSOR AGENTS IN SEPTIC SHOCK

Subject: Severe Sepsis/Septic Shock Published Date: August 9, 2013 Scope: Hospital Wide Original Creation Date: August 9, 2013

Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new?

Early Warning Scores (EWS) Clinical Sessions 2011 By Bhavin Doshi

Medical Direction and Practices Board WHITE PAPER

Inotropes/Vasoactive Agents Hina N. Patel, Pharm.D., BCPS Cathy Lawson, Pharm.D., BCPS

Common Ventilator Management Issues

Recommendations: Other Supportive Therapy of Severe Sepsis*

Chapter 16. Learning Objectives. Learning Objectives 9/11/2012. Shock. Explain difference between compensated and uncompensated shock

TACO vs. TRALI: Recognition, Differentiation, and Investigation of Pulmonary Transfusion Reactions

Core Measures SEPSIS UPDATES

Sepsis Reassess patient Monitor and maintain respiratory/ hemodynamic status

Inpatient Code Sepsis March Update. Sarah Prebil

Protocols for Early Extubation After Cardiothoracic Surgery

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

Quiz 5 Heart Failure scores (n=163)

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident

Sepsis: Identification and Treatment

SE5h, Sepsis Education.pdf. Surviving Sepsis

Section Four: Pulmonary Artery Waveform Interpretation

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Nursing Education and Research

Lynda Richardson, RN, BSN Sepsis/Septic Shock Abstractor. No disclosures

John Gasman, MD Alec Jamieson, RN, MSN Kim Clifforth, RN, BSN, MSN, CNS Thomas T. Lam, MD. June 18, 2013

CENTER FOR DRUG EVALUATION AND RESEARCH

Cardiogenic shock: invasive and non-invasive monitoring John T. Parissis Attikon University Hospital Athens, Greece

From AARC Protocol Committee; Subcommittee Adult Critical Care Version 1.0a (Sept., 2003), Subcommittee Chair, Susan P. Pilbeam

Decreasing Sepsis Mortality at the University of Colorado Hospital

Procedure for Inotrope Administration in the home

NORTH WALES CRITICAL CARE NETWORK

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) S. Agarwal, MD, S. Kache MD

Mechanical Ventilation for Dummies Keep It Simple Stupid

3100B Clinical Training Program. 3100B HFOV VIASYS Healthcare

240- PROBLEM SET INSERTION OF SWAN-GANZ SYSTEMIC VASCULAR RESISTANCE. Blood pressure = f(cardiac output and peripheral resistance)

STAGES OF SHOCK. IRREVERSIBLE SHOCK Heart deteriorates until it can no longer pump and death occurs.

Safe Zone: CV PIP < 26; HFOV: MAP < 16; HFJV: MAP < 16 Dopamine infusion up to 20 mcg/kg/min Epinephrine infusion up to 0.1 mcg /kg/min.

KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE (GEN. ORG.) NURSING AFFAIRS. Scope of Service PEDIATRIC INTENSIVE CARE UNIT (PICU)

Waveforms. INTRODUCTION TO THE HEARTWARE WAVEFORM ipad APP

Non-Invasive Positive Pressure Ventilation in Heart Failure Patients: For Who, Wy & When?

Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, NP Education Specialist LRM Consulting Nashville, TN

It is recommended that the reader review each medical directive presented in this presentation along with the actual PCP Core medical directive.

Edwards FloTrac Sensor & Edwards Vigileo Monitor. Measuring Continuous Cardiac Output with the FloTrac Sensor and Vigileo Monitor

THE AIRWAY IN AEROMEDICAL EVACUATION. PBLD (Problem Based Learning Discussion)

Levels of Critical Care for Adult Patients

Milwaukee School of Engineering Case Study: Factors that Affect Blood Pressure Instructor Version

Importance of Protocols in the Decision to Use Noninvasive Ventilation

Introduction Hypothesis Methods Results Conclusions Figure 11-1: Format for scientific abstract preparation

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center

Treatment of cardiogenic shock

Local Anaesthetic Systemic Toxicity. Dr Thomas Engelhardt, MD, PhD, FRCA Royal Aberdeen Children s Hospital, Scotland

Advantages and disadvantages of CRRT in ARF patients. Norbert Lameire Renal Division University Hospital Ghent, Belgium

Aktuelle Literatur aus der Notfallmedizin

CRITICAL CARE MONITORING: WHAT, WHEN, AND HOW? Susan G. Hackner, BVSc.MRCVS.DACVIM.DACVECC.

Guidelines for diagnosis and management of acute pulmonary embolism

RGN JOY LAUDE WATFORD GENERAL HOSPITAL, ENGLAND

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

International Guidelines for Management of Severe Sepsis and Septic Shock

Both clinical condition and treatment criteria must be met to qualify for critical care coding.

Oxygenation. Chapter 21. Anatomy and Physiology of Breathing. Anatomy and Physiology of Breathing*

Emergency Fluid Therapy in Companion Animals

Pulmonary Diseases. Lung Disease: Pathophysiology, Medical and Exercise Programming. Overview of Pathophysiology

Dr Anne Weaver London s Air Ambulance CODE RED THE BLEEDING PATIENT

ACLS PHARMACOLOGY 2011 Guidelines

IMPAIRED BLOOD-GAS EXCHANGE. Intraoperative blood gas analysis

What is the Future of Epinephrine in Cardiac Arrest? Pros and Cons

Inotrope and Vasopressor Therapy of Septic Shock

James F. Kravec, M.D., F.A.C.P

Postoperative management in adults

Management of septic shock with a norepinephrine-based haemodynamic algorithm

BOARD OF PHARMACY SPECIALITIES 2215 Constitution Avenue, NW Washington, DC FAX

404 Section 5 Shock and Resuscitation. Scene Size-up. Primary Assessment. History Taking

A National Early Warning Score for the NHS

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Extracorporeal Life Support Organization (ELSO) Guidelines for Neonatal Respiratory Failure

She was 39 years old, gravida 4, para 2. She had an Idiopathic Pulmonary. Arterial Hypertension (PAH) revealed during pregnancy by a New York Heart

It is important to be able to predict

Pain Management in the Critically ill Patient

Clinical Practice Guidelines for Blood Transfusions

Vtial sign #1: PULSE. Vital Signs: Assessment and Interpretation. Factors that influence pulse rate: Importance of Vital Signs

Perioperative Management of Patients with Obstructive Sleep Apnea. Kalpesh Ganatra,MD Diplomate, American Board of Sleep Medicine

Chapter 2 Vasopressors and Inotropes

PULMONARY PHYSIOLOGY

Hemodynamic Monitoring: Principles to Practice M. L. Cheatham, MD, FACS, FCCM

5/30/2014 OBJECTIVES THE ROLE OF A RESPIRATORY THERAPIST IN THE DELIVERY ROOM. Disclosure

Transcription:

HOW TO PRACTICALLY USE THE VARIOUS MONITORING SYSTEMS? The PiCCO system Azriel Perel Professor and Chairman Department of Anesthesiology and Intensive Care Sheba Medical Center, Tel Aviv University Israel Rome 2009 Disclosure The speaker cooperates with the following companies BMeye Drager-Siemens Pulsion perelao@shani.net 1

The PiCCO A multi-parametric approach to advanced hemodynamic monitoring The PiCCO Central venous catheter Thermistor-tipped tipped arterial catheter Femoral Axillary Brachial Radial (long) { 2

Clinical examination, vital signs, urine output, Hb, lactate... Preload & Fluid responsiveness EVLW Cardiac Output dp/dt, CFI, GEF, PVPI ScvO 2 Clinical examination, vital signs, urine output, Hb, lactate... Preload & Fluid responsiveness EVLW Cardiac Output dp/dt, CFI, GEF, PVPI ScvO 2 3

A man with fever and shortness of breath ScvO 2 72% CVP 9 mmhg Lactate 48 PaO 2 /FiO 2 75 (PEEP 10) CO 3.8 ITBVI 950 (normai) EVLWI 15 (high) SVR 1100 Real-time CCO by the pulse contour method P [mm Hg] t [s] PCCO = cal HR ( P(t) + C(p) dp ) dt SVR dt Systole Arterial compliance and resistance are updated Patient-specific Heart Area of ComplianceShape of beat-to-beat calibration factor according rate pressure to a proprietary pressure algorithm (determined with curve curve that depends thermodilution) particularly on the arterial pressure and on dp/dt. 4

Whole set of CI pairs Measurements recorded when SVR changed > 15% After a 1-hr calibration-free period, recalibration may be encouraged since it provides helpful information drawn from other thermodilution-derived variables. Clinical examination, vital signs, urine output, Hb, lactate... Preload & Fluid responsiveness EVLW Cardiac Output dp/dt, CFI, GEF, PVPI ScvO 2 5

Clinical examination, vital signs, urine output, Hb, lactate... Preload & Fluid responsiveness EVLW Cardiac Output dp/dt, CFI, GEF, PVPI ScvO 2 Intra-thoracic blood volume (ITBV) 50 c ICG [mg l -1 ] 40 30 mtt cent 70% ITBV = CO mtt 20 33% 10 0 0 10 20 30 40 50 60 RAEDV RVEDV LAEDV LVEDV RAEDV RVEDV [s] PBV LAEDV LVEDV t GEDV ITBV 6

Global End-Diastolic Volume as an Indicator of Cardiac Preload in Patients With Septic Shock F Michard et al, Chest. 2003;124:1900-1908 800 780 760 740 720 700 680 660 640 620 600 Pre-infusion GEDVi (ml/m 2 ) Responders Non-responders % of fluid-responders ITBV and its changes correlates to CI and its changes significantly better than the CVP Crit Care Med 2008; 36: 2348 7

Intravascular volume depletion in a 24-hour porcine model of intra-abdominal abdominal hypertension Schachtrupp A et al, J Trauma. 55: 734-740 740, 2003 Should we monitor preload and Should we monitor preload and fluid responsiveness in shock? 8

Functional hemodynamic parameters (SPV, PPV, SVV) are the most sensitive parameters for the assessment of fluid responsiveness in mechanically ventilated patients SPV PPV SVV Clinical examination, vital signs, urine output, Hb, lactate... Preload & Fluid responsiveness EVLW Cardiac Output dp/dt, CFI, GEF, PVPI ScvO 2 9

High EVLW content is associated with increased mortality (65-80% when EVLW>20 ml/kg) Sturm JA 1990 Sakka S et al Chest 2002; 1232:2080-6 N=373 Mortality (%) 90 80 70 60 50 40 30 20 EVLWI and Mortality (Highest measurement) Beale R 2001 2_6 6_8 8_10 10_12 12_16 16_20 >20 EVLWI (ml/kg) N=241 FT Chung et al, respiratory Medicine 2008 10

EVLW was markedly elevated (13.5 ml/kg) in patients with early ARDS, was significantly higher in nonsurvivors and correlated with Vd/Vt. PiCCO (ml/kg) EVLW- 40 30 20 10 R 2 = 0.9758 0 0 10 20 30 40 EVLW-grav. (ml/kg) 15 dogs; EVLW measured by PiCCO and, following sacrifice, by gravimetrics. Control (n=5) Non-cardiogenic pulmonary edema (oleic acid) (n=5) Cardiogenic pulmonary edema (lt. atrial balloon) (n=5) 11

A 63 yrs old patient with pulmonary edema after TURT 24 hours later 20 ml/kg 10 ml/kg Severe respiratory failure in a 33 yrs old patient following ruptured hematoma of the liver and multiple transfusions EVLW is only 5 ml/kg 12

A patient with head injury, severe ARDS and septic shock BP HR CVP 70/40 mmhg 155 bpm 5 cmh 2 O PaO 2 /FiO 2 80 (PEEP 16) Noradrenaline Would you give + fluids aggressive to this patient? diuresis! CO = 12-1515 L/min SVR = 400-500 ITBVI = 1200 ml/m 2 (800-1000) EVLW = 19-23 ml/kg (4-7) High!!! Low!!! High!!! High!!! An old patient with chronic heart failure, sepsis, severe respiratory failure and hemodynamic instability. CO 1.8 l/min LOW ITBVi EVLWi 600 ml/m 2 LOW 15 ml/kg HIGH SVV 25-30% HIGH A classic therapeutic (heart vs. lungs) conflict 13

Start fluid loading! 17.5 EVLW 30 Stop fluid loading! A 63 years old male patient; developed fulminant pulmonary edema 4 hours into a re-total hip replacement. Hypoxemia (SaO2<80%), hemodynamic instability and ST changes. In the PACU hypotensive, tachycardic, on vasopressors and inotropes. Parameter Normal range Interpretation CI 1.9 l/m 2 3.5-5.0 Low CO ITBVI 779 ml/m 2 850-1000 Low preload SVV 22 % <10 EVLW 23 ml/kg 3-7 High fluid responsiveness!! Severe pulmonary edema 14

R E S U L T S Decision tree for hemodynamic / volumetric monitoring** CI (l/min/m 2 ) <3.0 >3.0 GEDI (ml/m 2 ) or ITBI (ml/m 2 ) ELWI (ml/kg) CI (l/m 2 ) 1.9 ITBVI (ml/m 2 ) <700 <850 >700 >850 CO (L) <700 GEDV (L) <850 EVLW (H) >700 >850 <10 >10 <10 >10 <10 >10 <10 >10 Fluids cautiously + catecholamines V+ V+! Cat Cat V+ V+! V- Cat V- T GEDI (ml/m 2 ) >700 700-800 >700 700-800 >700 700-800 700-800 H 1. or ITBI (ml/m 2 ) >850 850-1000 >850 850-1000 E >850 850-1000 850-1000 R T + 2. Optimise tosvv (%) <10 <10 <10 <10 A A <10 <10 <10 <10 P R Y G E CFI (1/min) >4.5 >5.5 >4.5 >5.5 T or GEF (%) >25 >30 >25 >30 OK! SVV % 22 779 Start fluid loading! ELWI (ml/kg)* (slowly responding) 10 10 10 10 EVLW (ml/kg) V+= volume loading (! = cautiously) V-= volume contraction Cat = catecholamine / cardiovascular agents + SVV only applicable in ventilated patients without cardiac ythmia arrh 23 **without guarantee *not available in USA 29 R E S U L T S Decision tree for hemodynamic / volumetric monitoring** CI (l/min/m 2 ) <3.0 >3.0 GEDI (ml/m 2 ) or ITBI (ml/m 2 ) ELWI (ml/kg) CI (l/m 2 ) 3.75 ITBVI (ml/m 2 )!!! ELWI (ml/kg)* (slowly responding) <700 <850 CO (H) GEDV (H) >700 >850 EVLW (H) <700 <850 >700 >850 <10 >10 <10 >10 <10 >10 <10 >10 Diuresis V+ V+! Cat Cat V+ V+! V- Cat V- Stop fluid loading! T GEDI (ml/m 2 ) >700 700-800 >700 700-800 >700 700-800 700-800 H 1. or ITBI (ml/m 2 ) >850 850-1000 >850 850-1000 E 1444 >850 850-1000 850-1000 R T + 2. Optimise tosvv (%) <10 <10 <10 <10 A A <10 <10 <10 <10 P R Y G E CFI (1/min) >4.5 >5.5 >4.5 >5.5 T or GEF (%) >25 >30 >25 >30 OK! SVV % 15 10 10 10 10 EVLW (ml/kg) V+= volume loading (! = cautiously) V-= volume contraction Cat = catecholamine / cardiovascular agents + SVV only applicable in ventilated patients without cardiac ythmia arrh **without guarantee 15 *not available in USA 30 15

This flash permeability of uncertain etiology (TRALI?) was associated with severe hypovolemia and improved spontaneously even though fluids were liberally administered Table 2 PACU Fluid loading Postop Day 1 Postop Day 2 CI (l/m 2 ) 1.9 3.75 2.89 3.47 ITBVI (ml/m 2 ) 779 1444!!! 972 1093 SVV % 22 15 EVLW (ml/kg) EVLW / ITBV 23 15 1.82 *PEF/plasma TP ratio=1 * 0.73 8 5 0.36 7 4 0.26 Clinical examination, vital signs, urine output, Hb, lactate... Preload & Fluid responsiveness EVLW Cardiac Output dp/dt, CFI, GEF, PVPI ScvO 2 16

34 yr female; Very severe respiratory failure; Hemodynamic collapse; on noradrenaline. BP 113 / 67 mmhg CI 2.7 l/min/m 2 HR 91 bpm ITBVi 578 ml/m 2 Urine Good SaO 2 86%!!! ScvO 2 80%!!! EVLWi 20 ml/kg ICG PDR 6.7% (LiMON) (18-25%) Have we achieved initial resuscitation goals in this patient? 17

The PiCClin Study A Perel, M Maggiorini, M Malbrain, JL Teboul, J Belda, E Fernández-Mondéjar, M Kirov, J Wendon The patient population included 206 patients, which were evaluated by 166 residents and 146 specialists (total of 315 questionnaires). Participants i t were asked to predict advanced d hemodynamic parameters and decide on a therapeutic plan prior to PiCCO insertion. The PiCClin Study A Perel, M Maggiorini, M Malbrain, JL Teboul, J Belda, E Fernández-Mondéjar, M Kirov, J Wendon The main reasons for using the PiCCO monitoring system included: Unclear fluid status (136) Suspected sepsis / septic shock (89) Respiratory failure (59) Cardiogenic shock (24) Renal failure (32) Other (21) 18

The accuracy of predicted cardiopulmonary parameters CO (n=315) SVR (n=312) GEDVi (n=314) EVLWi (n=304) Underestimation >20% 170 (54%) 46 (14.7%) 97 (30.9%) 83 (27.3%) Within ± 20% 110 (34.9%) 107 (34.3%) 154 (49%) 124 (40.8%) Overestimation >20% 35 (11.1%) 159 (51%) 63 (20.1%) 97 (31.9%) The PiCClin Study The PiCClin Study II: Change of therapeutic plan following advanced rdiopulmonary monitoring in critically ill patients In the absence of further hemodynamic information, what would be your therapeutic decision? Fluid loading Red blood cells Inotropic agent Vasoconstrictor Diuretic Dialysis/ filtration Other 19

The PiCClin Study II: Change of therapeutic plan following advanced rdiopulmonary monitoring in critically ill patients. Original therapeutic plan Fluids (n=315) Pursued 67.6% Changed 32.4% Inotropes 78.4% 21.6% Vasoconstrictors Diuretics 77.5% 86.1% 22.5% 13.9% Forty-six patients with SAH treated within 24 hours of the ictus were investigated. A fluid management protocol emphasizing supplemental colloid administration was used to attain the following targets: CI - 3.0 L/min/m 2 GEDVi - 700-900 ml/m 2 EVLW < 14 ml/kg 20

Initially the CI was high (5.3 L/min/m 2 ) and the GEDVi low (555 ml/m 2 ), with elevations of plasma adrenaline, noradrenaline, and cortisol. CI progressively decreased and GEDVi was normalized by fluid administration aimed at normovolemia. Mutoh et al 21

Guiding therapy by an algorithm based on GEDVI leads to a shortened and reduced need for vaso-pressors, catecholamines, mechanical ventilation, and ICU therapy in patients undergoing cardiac surgery. Norepinephrine Epinephrine Goepfert et al, ICM 2007 The use of PiCCO resulted in: 1. Early recognition of hypovolemia and myocardial depression. 2. Better titration of fluid and inotrope / vasopressor therapy. 3. Shorter hospital length of stay after OPCAB. 22

Targeting EVLW in ARDS n=101 22 days * * 15 days 9 days 7 days RHC group EVLW group RHC group EVLW group Ventilation days ICU days After: Mitchell et al, Am Rev Resp Dis 145: 990-998, 1992 When EVLW is high C. Philips et al 23

This protocol allows aggressive diuresis of excess preload even during periods of shock something not done in the FACTT trial and rarely done clinically. This is accomplished by better identifying preload state using superior metrics of preload and cardiovascular status GEDI, CI, and EVLW. C. Philips (with permission) How should the PiCCO be used? 1. Is there a problem? 2. Identify the problem(s) 3. Which seems to be the most critical problem? 4. Is there a therapeutic conflict? 5. Out of your potential therapeutic options, which decision will cause most/least damage in case of error? 6. Make your decision and follow results 7. Go back to (1) 24

When do I use the PiCCO? CHF + major surgery Sepsis ARDS, MOF Pulmonary edema Therapeutic conflicts Expected hemodynamic instability When the patient cannot afford to pay the price of my mistake Conclusion Critically ill patients do often have complex hemodynamics and may often present us with heart-lung and other therapeutic conflicts. Since all individual hemodynamic parameters have limitations and confounding factors, a multi-parametric hemodynamic approach that includes EVLW reduces the chance of erroneous critical decisions. 25

Clinical examination, vital signs, urine output, Hb, lactate... Preload & Fluid responsiveness EVLW Cardiac Output dp/dt, CFI, GEF, PVPI ScvO 2 Thank you! 26

Cardiac output 6.77 L/min ScvO 2 is 60%! Is this CO adequate? Patient is given dobutamine CO ScvO 2 =63 ScvO 2 =74 ScvO 2 =76 CO was high, but not high enough! The CO and the ScvO 2 complement each other! 27